PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive brain cancer: trial tests powerful drug cocktail
Disease control Not yet recruitingThis study is testing whether adding one or two new drugs (orelabrutinib and teniposide) to standard chemotherapy works better for newly diagnosed primary brain lymphoma. Researchers will randomly assign 215 adults to receive different drug combinations to see which helps more pa…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New test could spot deadly drug side effects before they strike brain cancer patients
Knowledge-focused Not yet recruitingThis study aims to develop a better way to monitor patients with a rare brain cancer (primary central nervous system lymphoma) who are receiving a key chemotherapy drug called methotrexate. The drug can cause serious kidney damage, which can delay further life-saving treatments. …
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC